TARGET DECK: MED::I::Signaling Pathways in Health and Disease::Metabolic Biochemistry::09 - Gluconeogenesis
Gluconeogenesis — Overview
Why Gluconeogenesis?
- The brain depends on a continuous supply of glucose: it cannot synthesize glucose or store much glycogen.
- All glucose in the bloodstream can supply the brain for no more than one hour → hypoglycemia has rapid neural consequences.
- When dietary sources are unavailable and liver glycogen is exhausted, glucose must be synthesized from non-carbohydrate sources.
- Gluconeogenesis can provide a substantial part of blood glucose just a few hours after eating.
Primary (only) sites of gluconeogenesis: Liver, kidney cortex
Gluconeogenic sources:
- Lactate
- Pyruvate (ending point of glycolysis)
- Glycerol
- Glucogenic amino acids:
- These can be converted into pyruvate or other intermediates:
- Gly, Ala, Cys, Ser, Asp, Asn, Glu, Gln, Pro, Arg, His, Val, Met, Thr
- Partly glucogenic: Trp, Ile, Phe, Tyr
What are the primary sites of gluconeogenesis?
Liver and kidney cortex.
Anki cloze
The brain cannot store significant glycogen, and all blood glucose can supply it for no more than {1:one hour}, making gluconeogenesis essential during fasting.
Gluconeogenic Precursors — Metabolic Entry Points
| Precursor | Entry Point |
|---|---|
| Glycerol | Glycerol-3-P → DHAP |
| Lactate / Alanine | Pyruvate |
| Glucogenic amino acids | Pyruvate or TCA intermediates → Oxaloacetate |
| TCA intermediates (from FA oxidation) | Oxaloacetate |
Warning
Fatty acids are NOT glucogenic Acetyl-CoA (product of FA oxidation) cannot provide net synthesis of oxaloacetate → fatty acids cannot be converted to glucose.
The Cori Cycle
Cori Cycle
Intercellular cycle between muscle and liver:
- Muscle: Glucose → (Glycolysis) → Pyruvate → (LDH) → Lactate +
- Liver: Lactate → (LDH) → Pyruvate → (Gluconeogenesis) → Glucose (costs , )
What is the Cori Cycle?
The metabolic cycle in which lactate produced by anaerobic glycolysis in muscle is transported to the liver, converted back to pyruvate, and used for gluconeogenesis to regenerate glucose.
The Alanine Cycle
Alanine Cycle
Parallel to the Cori cycle, but carries nitrogen as well as carbon:
- Muscle: Amino acids → transamination → Alanine + α-ketoglutarate (from pyruvate + via glutamate)
- Alanine travels in blood to liver
- Liver: Alanine → pyruvate → gluconeogenesis; nitrogen enters the urea cycle
How does the Alanine Cycle differ from the Cori Cycle?
The Alanine Cycle transports both carbon (as pyruvate) and nitrogen (as an amino group) from muscle to liver, while the Cori Cycle transports only carbon (as lactate). Nitrogen from the Alanine Cycle feeds into the urea cycle in the liver.
Gluconeogenesis vs. Glycolysis — General Relationship
Key Principle
Gluconeogenesis follows glycolysis in reverse, except for three irreversible reactions, which are bypassed by three distinct sets of reactions. While glycolysis is entirely cytosolic, the first bypass of gluconeogenesis involves mitochondrial steps.
The Three Bypasses of Gluconeogenesis
First Bypass — Pyruvate → Phosphoenolpyruvate
Glycolytic reaction (irreversible):
Bypass reactions:
-
Pyruvate carboxylase (mitochondrial):
-
PEP carboxykinase (PEPCK):
Energetics of First Bypass
The overall free energy change is strongly negative (), making this bypass effectively irreversible.
What two enzymes bypass the pyruvate kinase reaction in gluconeogenesis?
Pyruvate carboxylase (pyruvate → oxaloacetate) and PEP carboxykinase (oxaloacetate → PEP).
Anki cloze
Pyruvate carboxylase converts pyruvate to {1:oxaloacetate} using {2:} and {3:ATP}, and is exclusively {4:mitochondrial}.
Second Bypass — Fructose-1,6-bisphosphate → Fructose-6-phosphate
Glycolytic reaction (irreversible):
Bypass:
Third Bypass — Glucose-6-phosphate → Glucose
Glycolytic reaction (irreversible):
Bypass:
What are the three irreversible glycolytic reactions that are bypassed in gluconeogenesis, and what enzymes perform the bypass?
- Pyruvate kinase → bypassed by Pyruvate carboxylase + PEPCK
- PFK-1 → bypassed by FBPase-1
- Hexokinase/Glucokinase → bypassed by Glucose-6-phosphatase
Pyruvate Carboxylase — Structure and Mechanism
Pyruvate Carboxylase
- Exclusively mitochondrial
- Four subunits, each with:
- ATP + binding site
- Biotin-binding site (mobile arm — Vitamin B7/H)
- Pyruvate-binding site
- Allosteric site for acetyl-CoA
- Positively regulated by glucagon
- Negatively regulated by insulin
Mechanism:
Biotin is Vitamin B7 (also called Vitamin H) — water-soluble. It acts as a mobile carboxyl carrier on a long flexible arm.
What is the allosteric activator of pyruvate carboxylase?
Acetyl-CoA.
Anki cloze
Pyruvate carboxylase is {1:exclusively mitochondrial} and uses {2:biotin} as a cofactor (mobile arm) to transfer a carboxyl group from {3:} to pyruvate, forming {4:oxaloacetate}.
PEP Carboxykinase (PEPCK)
PEPCK
- Located in both mitochondria and cytosol
- Catalyzes phosphorylation from GTP and decarboxylation:
- The removed is the same carbon previously added by pyruvate carboxylase
Where is PEP carboxykinase (PEPCK) located?
Both in the mitochondria and cytosol (unlike pyruvate carboxylase, which is exclusively mitochondrial).
Reducing Power for Gluconeogenesis
Cytosolic NADH Requirement
Gluconeogenesis requires cytosolic NADH for the reduction of 1,3-BPG to glyceraldehyde-3-phosphate.
Source depends on gluconeogenic precursor:
| Carbon Source | How Cytosolic NADH is Generated |
|---|---|
| Lactate | (cytosolic LDH) |
| Amino acids | Malate exported from mitochondrion → oxidized in cytosol: |
Why is the malate shuttle used during gluconeogenesis from amino acids?
Oxaloacetate cannot cross the mitochondrial membrane, so it is first reduced to malate (which can cross), then re-oxidized to oxaloacetate in the cytosol — simultaneously generating the cytosolic NADH needed for gluconeogenesis.
Gluconeogenesis from Amino Acids
Entry Points into the Pathway
| Entry Point | Amino Acids |
|---|---|
| Pyruvate | Ala, Cys, Gly, Ser, Trp* |
| α-Ketoglutarate | Arg, Glu, Gln, His, Pro |
| Succinyl-CoA | Ile*, Met, Thr, Val |
| Fumarate | Phe*, Tyr* |
| Oxaloacetate | Asn, Asp |
*Also ketogenic
Purely Ketogenic Amino Acids (NOT glucogenic)
Leucine and Lysine — broken down only to acetyl-CoA and/or acetoacetyl-CoA; they cannot furnish net carbon for glucose synthesis.
Mnemonic — "Leu and Lys are the Lonely Ketones"
Leucine and Lysine = the only Locked-out amino acids (purely ketogenic, never glucogenic).
Specific metabolic routes:
- Alanine → Pyruvate → Oxaloacetate → Malate → cytosol
- Aspartate → Oxaloacetate → Malate → cytosol
- Glutamate → α-Ketoglutarate → Succinyl-CoA → … → Malate → cytosol
- Valine → Succinyl-CoA → … → Malate → cytosol
Which two amino acids are purely ketogenic and cannot contribute to gluconeogenesis?
Leucine (Leu) and Lysine (Lys).
Anki cloze
Aspartate enters gluconeogenesis at the level of {1:oxaloacetate}, while alanine first becomes {2:pyruvate} before being carboxylated to oxaloacetate.
Routes for Cytosolic OAA — Two Variants of the First Bypass
When lactate is the precursor
- Lactate → pyruvate (cytosolic LDH, generating NADH)
- Pyruvate enters mitochondria → carboxylated to OAA by pyruvate carboxylase
- Cytosolic PEPCK converts OAA → PEP directly in cytosol
- Malate shuttle not primarily needed (NADH already provided by LDH)
When amino acids are the precursor
- OAA in mitochondria → reduced to malate → exported
- Malate → OAA in cytosol (generates cytosolic NADH)
- Cytosolic PEPCK converts OAA → PEP
Overall Stoichiometry of Gluconeogenesis
Sequential reactions from pyruvate:
| Reaction | Enzyme | ×n |
|---|---|---|
| Pyruvate + + ATP → OAA + ADP + | Pyruvate carboxylase | ×2 |
| OAA + GTP → PEP + + GDP | PEPCK | ×2 |
| PEP + → 2-phosphoglycerate | Enolase | ×2 |
| 2-PG → 3-PG | Phosphoglycerate mutase | ×2 |
| 3-PG + ATP → 1,3-BPG + ADP | Phosphoglycerate kinase | ×2 |
| 1,3-BPG + NADH → G3P + NAD + | GAPDH | ×2 |
| G3P → DHAP | Triose phosphate isomerase | ×1 |
| G3P + DHAP → Fructose-1,6-bisP | Aldolase | ×1 |
| Fructose-1,6-bisP + → Fructose-6-P + | FBPase-1 (bypass) | ×1 |
| Fructose-6-P → Glucose-6-P | Phosphoglucose isomerase | ×1 |
| Glucose-6-P + → Glucose + | Glucose-6-phosphatase (bypass) | ×1 |
Anki cloze
Gluconeogenesis from 2 pyruvate costs {1:4 ATP}, {2:2 GTP}, and {3:2 NADH} — significantly more energy than is gained by glycolysis ({4:2 ATP net}).
Physiological Role of Gluconeogenesis
Why gluconeogenesis is necessary Brain, nervous system, and red blood cells generate ATP mainly from glucose. Gluconeogenesis:
- Allows generation of glucose when glycogen stores are depleted (starvation, vigorous exercise)
- Can generate glucose from many amino acids, but not from fatty acids
During prolonged starvation
- Initial fuel: amino acids (gluconeogenic)
- Gradually, body shifts to protect critical proteins and enzymes
- Brain shifts from all-glucose to glucose + ketone bodies (acetone, acetoacetate, β-hydroxybutyrate) derived from FA oxidation
Gluconeogenesis from Glycerol
Glycerol is the only glucogenic part of lipids (the glycerol backbone of triacylglycerols):
OCC(O)CO(Glycerol)
What part of a lipid molecule can be used for gluconeogenesis?
The glycerol backbone (only). Fatty acids cannot contribute to net glucose synthesis.
What CANNOT Be Used for Gluconeogenesis
Not fuel for gluconeogenesis
- Acetyl-CoA
- Fatty acids (broken down to acetyl-CoA)
- Leucine and Lysine (broken down only to acetyl-CoA / acetoacetyl-CoA)
There is no path for the NET synthesis of oxaloacetate from acetyl-CoA.
However, fatty acid oxidation provides much of the ATP that fuels gluconeogenesis.
Acetyl-CoA as a Metabolic Signal
Acetyl-CoA signals that further glucose oxidation is not needed:
- Allosterically stimulates pyruvate carboxylase → promotes gluconeogenesis
- Allosterically inhibits pyruvate dehydrogenase complex → prevents further pyruvate → acetyl-CoA
How does acetyl-CoA coordinate gluconeogenesis and glucose oxidation?
Acetyl-CoA allosterically activates pyruvate carboxylase (promoting gluconeogenesis) and allosterically inhibits pyruvate dehydrogenase (blocking further oxidation of pyruvate).
Regulation of Gluconeogenesis in the Liver
Hormonal Regulation
| Hormone | Effect on Gluconeogenesis | Effect on Glycolysis |
|---|---|---|
| Glucagon | ↑ (stimulates) | ↓ (inhibits) |
| Insulin | ↓ (inhibits) | ↑ (stimulates) |
| Cortisol | ↑ (stimulates) | — |
Anki cloze
The major regulatory step in gluconeogenesis is at the level of {1:PFK-1} (glycolysis) and {2:FBPase-1} (gluconeogenesis), at the interconversion of {3:fructose-6-phosphate} and {4:fructose-1,6-bisphosphate}.
Fructose-2,6-Bisphosphate (F-2,6-bP) — Key Allosteric Regulator
F-2,6-bP is NOT a glycolytic intermediate — it is a regulatory molecule only
| Effect of F-2,6-bP | Target | Pathway |
|---|---|---|
| Allosteric activation | PFK-1 | Glycolysis ↑ |
| Allosteric inhibition | FBPase-1 | Gluconeogenesis ↓ |
What is the role of fructose-2,6-bisphosphate in metabolic regulation?
It allosterically activates PFK-1 (promoting glycolysis) and inhibits FBPase-1 (suppressing gluconeogenesis). It is a regulatory molecule, not a metabolic intermediate.
The Tandem Enzyme PFK-2/FBPase-2
PFK-2 and FBPase-2 are contained in the same bifunctional protein
Regulation by phosphorylation state:
| State | Active Domain | F-2,6-bP Level | Metabolic Effect |
|---|---|---|---|
| Dephosphorylated | PFK-2 (kinase) | ↑ High | Stimulates glycolysis, inhibits gluconeogenesis |
| Phosphorylated | FBPase-2 (phosphatase) | ↓ Low | Inhibits glycolysis, stimulates gluconeogenesis |
Hormonal control:
PP2A (Protein Phosphatase 2A) is also activated by xylulose-5-phosphate.
What happens to the PFK-2/FBPase-2 tandem enzyme when glucagon levels rise?
Glucagon → cAMP → PKA phosphorylates the tandem enzyme → FBPase-2 becomes active (PFK-2 inactive) → F-2,6-bP falls → PFK-1 inhibited, FBPase-1 activated → gluconeogenesis increases.
Anki cloze
Phosphorylation of the PFK-2/FBPase-2 bifunctional enzyme activates {1:FBPase-2}, while dephosphorylation activates {2:PFK-2}. Glucagon promotes {3:phosphorylation} via {4:PKA}.
Additional Allosteric Regulation of PFK-1/FBPase-1
| Effector | Effect on PFK-1 | Effect on FBPase-1 |
|---|---|---|
| F-2,6-bP | Activates ↑ | Inhibits ↓ |
| AMP, ADP | Activates ↑ | — |
| ATP | Inhibits ↓ (negative effector AND substrate) | — |
| Citrate | Inhibits ↓ | — |
| AMP | — | Inhibits ↓ |
What is the dual role of ATP at PFK-1?
ATP is both a substrate for PFK-1 and a negative allosteric effector — at high concentrations it inhibits PFK-1, slowing glycolysis when energy charge is high.
Transcriptional Regulation of Gluconeogenesis
| Transcription Factor | Activator | Effect |
|---|---|---|
| CREB | Glucagon → cAMP | Induces gluconeogenic enzymes |
| ChREBP | Insulin → PP2A | Induces glycolytic and insulin-dependent enzymes |
| SREBP | Insulin | Induces glycolytic enzymes; represses glucogenic enzymes |
| FOXO1 | (constitutive; inhibited by insulin) | Stimulates gluconeogenic enzymes |
FOXO1 and Insulin Insulin → PKB (Akt) → phosphorylates FOXO1 → FOXO1 undergoes ubiquitin-mediated degradation → gluconeogenic gene expression ↓
How does insulin suppress gluconeogenic gene expression via FOXO1?
Insulin activates PKB (Akt), which phosphorylates FOXO1, targeting it for ubiquitin-mediated degradation, thereby reducing transcription of gluconeogenic enzymes.
Nutritional Sensors of Metabolism
Sensors of Low Energy / Low Nutritional Intake
(Activate catabolic pathways, gluconeogenesis, mitochondrial function)
- AMPK — AMP-dependent protein kinase
- Sirtuins — protein deacetylases
- PGC-1α (PPAR-γ Coactivator 1α) — activates mitochondrial biogenesis
- FOXO — transcription factor
Sensors of High Nutritional State
(Activate anabolic pathways, protein synthesis, growth)
- Insulin
- IGF — Insulin-like Growth Factor
- mTOR (Target of Rapamycin) — activated by PKB
What does AMPK sense and what pathways does it activate?
AMPK senses a low energy state (high AMP:ATP ratio) and activates catabolic pathways including gluconeogenesis and mitochondrial function.
Clinical Disorders of Gluconeogenesis
| Disorder | Prevalence | Key Features |
|---|---|---|
| Glucose-6-phosphatase deficiency | ~1/100,000 | Glycogen storage disease |
| Pyruvate carboxylase deficiency | <1/250,000 | No survival beyond infancy |
| PEPCK deficiency | Very rare (5–6 cases) | No survival beyond infancy |
| FBPase-1 deficiency | ~1/500,000 | Rapid-onset hypoglycemia on fasting; lactic acidosis (NADH buildup); managed by avoiding fructose/sucrose and glucose infusion |
FBPase-1 Deficiency
- Presents with rapid-onset hypoglycemia during fasting
- Lactic acidosis due to NADH buildup (nausea, vomiting, weakness)
- Clinical management: avoid fructose and sucrose; glucose infusion
Why does FBPase-1 deficiency cause lactic acidosis?
Without FBPase-1, gluconeogenesis is blocked, so lactate cannot be converted to glucose. Lactate accumulates, and NADH builds up, causing lactic acidosis.
TLDR - 09 - Gluconeogenesis
Gluconeogenesis — Comprehensive Summary
- Definition: Synthesis of glucose from non-carbohydrate precursors; occurs mainly in liver and kidney cortex
- Gluconeogenic precursors: Lactate, pyruvate, glycerol, and most amino acids (all except Leu and Lys)
- Fatty acids are NOT glucogenic — acetyl-CoA cannot provide net OAA synthesis; only glycerol(from TAG) can
- Three irreversible glycolytic steps are bypassed by unique enzymes:
- Pyruvate kinase → Pyruvate carboxylase (mito) + PEPCK (mito + cyto)
- PFK-1 → FBPase-1
- Hexokinase → Glucose-6-phosphatase
- Pyruvate carboxylase: mitochondrial only; requires biotin (B7); activated by acetyl-CoA; stimulated by glucagon, inhibited by insulin
- PEPCK: both mitochondrial and cytosolic; removes the same CO₂ added by pyruvate carboxylase
- Cytosolic NADH needed for 1,3-BPG → G3P; provided by LDH (lactate source) or malate shuttle (amino acid source)
- Overall cost: 2 Pyruvate + 4 ATP + 2 GTP + 2 NADH → Glucose + 6 Pᵢ + 2 NAD⁺
- Cori Cycle: muscle lactate → liver gluconeogenesis → glucose back to muscle
- Alanine Cycle: muscle amino acids → alanine → liver gluconeogenesis + urea cycle
- Key regulatory step: PFK-1 (glycolysis) vs. FBPase-1 (gluconeogenesis), regulated by F-2,6-bP
- F-2,6-bP: activates PFK-1 (glycolysis ↑); inhibits FBPase-1 (gluconeogenesis ↓); controlled by bifunctional PFK-2/FBPase-2
- Hormonal regulation: Glucagon → PKA → phosphorylates PFK-2/FBPase-2 → FBPase-2 active → F-2,6-bP ↓ → gluconeogenesis ↑; Insulin → reverse; Cortisol → gluconeogenesis ↑
- Transcriptional regulation: CREB (glucagon/cAMP), ChREBP & SREBP (insulin), FOXO1 (pro-gluconeogenic; degraded by insulin/PKB)
- Nutritional sensors — low energy: AMPK, Sirtuins, PGC-1α, FOXO → activate catabolism & gluconeogenesis
- Nutritional sensors — high energy: Insulin, IGF, mTOR (via PKB) → activate anabolism
- Acetyl-CoA: dual signal — activates pyruvate carboxylase (GNG ↑) and inhibits pyruvate dehydrogenase (glycolysis ↓)
- Clinical disorders: Deficiencies of G6Pase, pyruvate carboxylase, PEPCK (lethal in infancy); FBPase deficiency causes hypoglycemia + lactic acidosis